Calcium channel blockers, more than diuretics, enhance vascular protective effects of angiotensin receptor blockers in salt-loaded hypertensive rats

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Yamamoto, Eiichiro ^a   Kataoka, Keiichiro ^a   Dong, Yi Fei ^a,b   Koibuchi, Nobutaka ^a   Toyama, Kensuke ^a   Sueta, Daisuke ^a   Katayama, Tetsuji ^a   Yasuda, Osamu ^c   Ogawa, Hisao ^a   Kim Mitsuyama, Shokei ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

^b NANCHANG UNIVERSITY   (China)

^c KUMAMOTO UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZELNIDIPINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; HYDROCHLOROTHIAZIDE; MITOGEN ACTIVATED PROTEIN KINASE; OLMESARTAN; PROTEIN KINASE B; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; SODIUM CHLORIDE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE REGULATION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; HYPERTENSION; MALE; MONOTHERAPY; NONHUMAN; OXIDATIVE STRESS; RAT; SALT LOADING; STROKE PRONE SPONTANEOUSLY HYPERTENSIVE RAT; VASCULAR ENDOTHELIUM;

ANGIOTENSIN RECEPTOR ANTAGONISTS; ANIMALS; CALCIUM CHANNEL BLOCKERS; DIURETICS; HYPERTENSION; OXIDATIVE STRESS; RATS;

EID: 84862260648     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039162     Document Type: Article

References (17)

1. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, et al. (2007) 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J 28: 1462-1536.
2. Ogihara T, Kikuchi K, Matsuoka H, Fujita T, Higaki J, et al. (2009) The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res 32: 3-107.
3. Meneton P, Jeunemaitre X, de Wardener HE, MacGregor GA, (2005) Links between dietary salt intake, renal salt handling, blood pressure, and cardiovascular diseases. Physiol Rev 85: 679-715.
4. Morimoto A, Uzu T, Fujii T, Nishimura M, Kuroda S, et al. (1997) Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 350: 1734-1737.
5. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M, (2001) Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension 37: 429-432.
6. Cai H, Harrison DG, (2000) Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 87: 840-844.
7. Forstermann U, Munzel T, (2006) Endothelial nitric oxide synthase in vascular disease: from marvel to menace. Circulation 113: 1708-1714.
8. Griendling KK, Sorescu D, Ushio-Fukai M, (2000) NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 86: 494-501.
9. Mueller CF, Laude K, McNally JS, Harrison DG, (2005) ATVB in focus: redox mechanisms in blood vessels. Arterioscler Thromb Vasc Biol 25: 274-278.
10. Yamamoto E, Kataoka K, Shintaku H, Yamashita T, Tokutomi Y, et al. (2007) Novel mechanism and role of angiotensin II induced vascular endothelial injury in hypertensive diastolic heart failure. Arterioscler Thromb Vasc Biol 27: 2569-2575.
11. Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, Dong YF, et al. (2007) Role of xanthine oxidoreductase in the reversal of diastolic heart failure by candesartan in the salt-sensitive hypertensive rat. Hypertension 50: 657-662.
12. Nakamura T, Yamamoto E, Kataoka K, Yamashita T, Tokutomi Y, et al. (2008) Beneficial effects of pioglitazone on hypertensive cardiovascular injury are enhanced by combination with candesartan. Hypertension 51: 296-301.
13. Jamerson K, Weber MA, Bakris GL, Dahlof B, Pitt B, et al. (2008) Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients. N Engl J Med 359: 2417-2428.
14. Tuomilehto J, Jousilahti P, Rastenyte D, Moltchanov V, Tanskanen A, et al. (2001) Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet 357: 848-851.
15. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM, (1996) Stress-activated protein kinases in cardiovascular disease. Circ Res 78: 947-953.
16. Gerthoffer WT, (2007) Mechanisms of vascular smooth muscle cell migration. Circ Res 100: 607-621.
17. Muslin AJ, (2008) MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets. Clin Sci (Lond) 115: 203-218.